Patent Portfolio
The Antiviral Emulsions™ technology platform is supported by issued intellectual property and related technical documentation developed to facilitate commercial evaluation and licensing discussions.
ApplicationsPortfolio Snapshot
- Issued U.S. Patent
- Supporting Documentation
- Commercial Licensing
- Technical Due Diligence
Protecting the Technology Platform
The intellectual property portfolio has been developed to protect key aspects of the technology platform, including proprietary material compositions, application methodologies, manufacturing concepts, and related commercial applications. Supporting documentation is available to qualified organizations during confidential review.
Issued Intellectual Property
Patent protection supporting commercialization and long-term technology development.
Application Methods
Protection directed toward treatment methodologies and related implementation concepts.
Commercial Rights
Structured to support licensing, strategic partnerships, and acquisition opportunities.
Supporting Records
Patent history, technical documentation, and related materials available through NDA.
Documentation Available
Review the Patent Documentation
Qualified organizations may request access to patent materials and supporting documentation through the NDA process.
Request NDA